New book by Larry Connors Click here Improve your trading - See how
"We established the Retailing Chain Management Head Office to further the implementation of our 5-year strategic development plan for the retailing chain business of China Yongxin," stated Mr. Yongxin Liu, Chairman and CEO of China Yongxin Pharmaceuticals, Inc. "This facility will allow us to plan for the expansion of the retailing chain through all levels, to integrate our resources and methodically execute on rolling out new stores. Concurrently, it will allow us to set up a standardized medicine retailing chain operation system, to construct a scalable operation that adopts international standards, and enjoys competition in the market. Additionally, the Head Office helps to create the China Yongxin retailing chain brand image with a unique chain operations pattern. So, in effect, this facility will help us to enhance our competitive advantage."
He added, "The establishment of the China Yongxin Retailing Chain Management Head Office signals that China Yongxin's retail chain business has entered into a new phase of growth. The implementation of a uniform 'VI' system, a standardized operations handbook, a uniform business management system, and standardized operations regulations provide a strong foundation for rapid enterprise growth and continuous expansion. It will lead our retail drugstore operations in a healthy, stable and continuous development direction."
About China Yongxin Pharmaceuticals
China Yongxin Pharmaceuticals Inc. (OTCBB: CYXN | Quote | Chart | News | PowerRating) was founded in 1993 as Changchun Yongxin Dirui Medical Co., Ltd. (Yongxin), a wholesale drug distributor. Its products include Chinese traditional medicines, chemical preparations, natural health products, cosmetics and medical equipment. China Yongxin began retail operations in 2001 and, in 2005, gained China's Jilin Province franchise rights from Medicine Shoppe China Inc. By the end of 2007, the Company had become a rapidly growing medicine distributor and retailer in the northeast of China. Currently, the company has five subsidiaries including 93 chain pharmacies.
Forward Looking Statements: This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. China Yongxin Pharmaceutical Inc. does not assume any duty to publicly update or revise the material contained herein.
Contact: Mr. Sam Liu COO China Yongxin Pharmaceuticals, Inc. (626) 581-9098 Email: Email Contact
SOURCE: China Yongxin Pharmaceuticals, Inc.
http://www2.marketwire.com/mw/emailprcntct?id=1B55BF1D8FECD74C
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
